Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Thom Dunn Thom Dunn is a writer focusing on home heating and cooling. He once ...